AGP Picks
View all

Gitega Political Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Gitega Political Times.

Press releases published on August 6, 2026

MANH Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. – MANH
ROSEN, LEADING INVESTOR COUNSEL, Encourages Datavault AI Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DVLT
Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit – Hagens Berman
Hyliion Investor News: If You Have Suffered Losses in Hyliion Holdings Corp. (NYSE American: HYLN), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
PNR Alert: Pentair plc (NYSE: PNR) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, October 2, 2026 Lead Plaintiff Deadline
Primoris Services Corporation Notice of September 21, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline
Ensign Investor News: If You Have Suffered Losses in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
HIMS & HERS HEALTH, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
JEF SHAREHOLDER ALERT: Jefferies Financial Group, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
MYRIAD GENETICS, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
DR. REDDY’S LABORATORIES INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Gitega Political Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.